PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50119C00061Exercise OPTION 4 CLIN 0006 DEVICE — Amgen Inc

Amgen Inc holds $2.3M across 2 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 1 related award in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Dec 31, 2027 PoP end — agencies typically plan 12–18 months ahead.

Barda - Aspr / Daappo / Barda Dcma

Awarding office

Amgen Inc

Recipient

Dec 31, 2027

PoP end

$4.9M

Obligated

541714

NAICS

AN73

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Amgen Inc — $90

Contract facts

NONE

Contract number75A50119C00061

AgencyBarda - Aspr / Daappo / Barda Dcma

Awarding officeBarda - Aspr / Daappo / Barda Dcma

IncumbentAmgen Inc

UEID92HARF1LKA9

NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN73

Place of performanceNEWBURY PARK, CA

Related solicitationBAA18100SOL00003

PoP end (current)Dec 31, 2027

Obligated$4.9M

EXERCISE OPTION 4 CLIN 0006 DEVICE FEASIBILITY (SELF ADMINISTRATION KIT), REVISE THE CONTRACTING OFFICER, ADDITIONAL FA… is a federal NONE award for Barda - Aspr / Daappo / Barda Dcma held by Amgen Inc. Estimated value $26.4M ($4.9M obligated). Current period of performance ends Dec 31, 2027. Last award drew 1 bidder. Place of performance: NEWBURY PARK, CA. Related solicitation BAA18100SOL00003.

EXERCISE OPTION 4 CLIN 0006 DEVICE FEASIBILITY (SELF ADMINISTRATION KIT), REVISE THE CONTRACTING OFFICER, ADDITIONAL FAR CLAUSES INCLUDED IN FULL TEXT WAS REVISED TO ADD HHSAR 352.232-71 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS ELECTRONIC SUBMISSION

Recompete timing

Public

● Expiring in 480 days

Current PoP ends Dec 31, 2027 (480 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.

Incumbent footprint

Public record

Amgen Inc — $2.3M obligated across 2 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$2.3M · 100% of firm total

Open full company profile →

Related awards

Same incumbent

75A50123C00040

NPLATE ADMINISTRATION KIT DEVELOPMENT FOR THE TREATMENT OF APPROVED INDICATIONS, INCLUDING…

$7.3M

Jun 30, 2028

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75A50119C00061?

75A50119C00061 (Exercise OPTION 4 CLIN 0006 DEVICE) is a Barda - Aspr / Daappo / Barda Dcma award with an estimated value of $26.4M, currently held by Amgen Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50119C00061?

Barda - Aspr / Daappo / Barda Dcma awarded 75A50119C00061 to Amgen Inc.

Who is the incumbent on 75A50119C00061?

Amgen Inc is the incumbent with $2.3M across 2 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2027.

When does Amgen Inc’s 75A50119C00061 come up for recompete?

SCOUT tracks a period-of-performance end of Dec 31, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75A50119C00061 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 20, 2026 · refreshed monthlyLatest procurement action Dec 19, 2025